8-KItem 2.02 · Results of OperationsItem 8.01 · Other EventsItem 9.01 · Financial Statements
Bio-Techne reports fourth-quarter results and declares $0.08 dividend
Filed with the SEC on · Summarized by InvestorsBot
Bio-Techne reported fourth-quarter fiscal 2026 revenue of $321.2 million, up 1% reported and 3% organically, with GAAP diluted EPS of $0.35 and adjusted EPS of $0.52 for the quarter ended June 30, 2026. The company declared a quarterly dividend of $0.08 per share, payable September 4, 2026, to shareholders of record August 24, 2026. Bio-Techne also said it is progressing toward its previously announced acquisition by Merck KGaA for $73 per share in cash, representing an enterprise value of approximately $11.3 billion.